Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
International Journal of Pharmaceutics|February 7, 2012
In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injuryJason C Stanwick, M Douglas Baumann, Molly S ShoichetJournal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2012
Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogelJason C Stanwick, M Douglas Baumann, Molly S ShoichetBiomaterials|July 27, 2010
Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injuryM Douglas Baumann, Catherine E Kang, Charles H Tator, et al.Cells, Tissues, Organs|July 17, 2012
Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injuryCatherine E Kang, M Douglas Baumann, Charles H Tator, et al.Methods (San Diego, Calif.)|August 16, 2008
A quantitative ELISA for bioactive anti-Nogo-A, a promising regenerative molecule for spinal cord injury repairM Douglas Baumann, James W Austin, Michael G Fehlings, et al.Progress in Brain Research|July 10, 2007
Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cordMolly S Shoichet, Charles H Tator, Peter Poon, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 16, 2009
An injectable drug delivery platform for sustained combination therapyM Douglas Baumann, Catherine E Kang, Jason C Stanwick, et al.Biomaterials|March 31, 2012
The effects of intrathecal injection of a hyaluronan-based hydrogel on inflammation, scarring and neurobehavioural outcomes in a rat model of severe spinal cord injury associated with arachnoiditisJames W Austin, Catherine E Kang, M Douglas Baumann, et al.Pageof 1